BPG is committed to discovery and dissemination of knowledge
Articles in Press
1/15/2026 4:11:19 AM | Browse: 4 | Download: 0
Publication Name World Journal of Gastroenterology
Manuscript ID 115299
Country China
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Berberine alleviates experimental colitis by enhancing gut-microbiota-dependent intestinal barrier function and suppressing gasdermin D activation
Manuscript Source Unsolicited Manuscript
All Author List Ping Yang, Ran Wang, Yu-Ping Zhou, Jin-Feng Wen and Dong-Xue Yang
Funding Agency and Grant Number
Funding Agency Grant Number
Zhejiang Provincial Natural Science Foundation of China LQ22H030004
Zhejiang Provincial Natural Science Foundation of China LBY23H200006
Medical Health Science and Technology Project of Zhejiang Provincial Health Commission 2024KY324
Zhejiang Provincial Traditional Chinese Medicine Science and Technology Project 2025ZL115
Ningbo “Kechuang Yongjiang 2035” Major Research and Development Program 2025Z150
Ningbo Top Medical and Health Research Program 2023020612
Corresponding Author Dong-Xue Yang, Assistant Professor, Ningbo Key Laboratory of Translational Medicine Research on Gastroenterology and Hepatology, The First Affiliated Hospital of Ningbo University, No. 247 Renmin Road, Jiangbei District, Ningbo 315020, Zhejiang Province, China. fyyangdongxue@nbu.edu.cn
Key Words Ulcerative colitis; Berberine; Gasdermin D; Intestinal inflammation; Intestinal microbiota
Core Tip Berberine alleviates dextran sulfate sodium-induced murine ulcerative colitis through a mechanism that involves gut microbiota-dependent enhancement of intestinal barrier function and suppression of gasdermin D activation. Fecal microbiota transplantation and cohousing studies underscore the pivotal role of the microbiota, while gasdermin D inhibition diminishes the therapeutic efficacy of berberine, suggesting a novel therapeutic target for colitis.
Citation Yang P, Wang R, Zhou YP, Wen JF, Yang DX. Berberine alleviates experimental colitis by enhancing gut-microbiota-dependent intestinal barrier function and suppressing gasdermin D activation. World J Gastroenterol 2026; In press
Received
2025-10-21 02:19
Peer-Review Started
2025-10-21 02:19
First Decision by Editorial Office Director
2025-11-25 09:26
Return for Revision
2025-11-25 09:26
Revised
2025-12-08 08:44
Publication Fee Transferred
2025-12-09 06:35
Second Decision by Editor
2026-01-15 02:34
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-01-15 04:11
Articles in Press
2026-01-15 04:11
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com